Abstract:
A lancing device includes a lancing mechanism, a floating probe and a pressure tip. The lancing mechanism includes a lancet carriage, a lancet holder slidably connected to the lancet carriage, and a lancet attached to the lancet holder. The pressure tip of the lancing device is configured for engaging a target site and creating a target site bulge. The floating probe is adapted to floatably contact the target site bulge and to operatively interact with the lance carriage to control a penetration depth of the lancet into the target site bulge. A method for lancing a target site includes providing the lancing device describe above and contacting the pressure tip of the lancing device with the target site. The pressure tip is then urged towards the target site to create a target site bulge with the floating probe of the lancing device floating on a surface of the target site bulge. Next, the target site bulge is lanced while the floating probe operatively interacts with the lance carriage to control a penetration depth of the lancet.
Abstract:
A call set-up system sets up a call, which could be a voice call, between, for example, terminals P and V using call agents Q, S and U through a plurality of packet switched networks 1, 2 which are interconnected by network address translation (NAT) devices R,T. The messages to successive call agents includes media addresses in the associated networks for the actual data packets of the call when it has been set up. It could be that the call signalling passes from call agent Q associated with network 1 to call agent S associated with network 2, and then to call agent U associated once again with network 1, for example, because the user in the network 2 (which could be the internet) was re-directing their calls back to a terminal (V) in network 1, which could be a private network. Under the current Session Initiation Protocol (SIP), the call set-up message passed by S to U would only include an address in network 2 (2.1), and U would send an address in network 1 (1.3) to terminal V, forcing the media path to traverse NAT devices R and T. With the modified signalling of the invention, which could be a modified version of SIP, the call set-up message also includes the media address sent to at least some preceding call agents, so S passes (2.1)[1.1] to U, enabling U to give the media address (1.1) local to its network 1 to V, enabling NAT resources to be saved. The call agents Q,S,U can be incorporated into NAT devices, and the media addresses can be encrypted or in the form of a reference.
Abstract:
Method and system for validating data residing on different servers is provided. The method includes providing a first user interface from a first location, said first user interface providing access to data residing on a server in the first location, a substantial copy of said data made available on a server in a second location; re-directing a user to a second user interface from the second location upon an event in the first location, said second user interface providing access to the validated data on the server in the second location; and initiating a validation mode for validating the substantial copy of the data on the server at the second location upon the event in the first location. A Validator module identifies one or more data added or updated to a metadata on the server at the second location based on said validation parameters; and verifies existence of said identified data in one or more data files on the server at the second location based on said validation parameters.
Abstract:
A packaged medical device includes upper and lower flexible sheets, a lance body and a test strip. The lance body includes upper and lower surfaces, an opening that extends between the upper and lower surfaces and a dermal tissue penetration member that projects into the lance body opening. The test strip has an opening therethrough and is attached to the lance body lower surface such that the dermal tissue penetration member is operatively aligned with the test strip opening. The upper flexible sheet is attached to the lance body upper surface and covers the lance body opening, while the lower flexible sheet is detachably attached to the test strip and covers the test strip opening. The upper flexible sheet, lance body and test strip are configured such that, when the lower flexible sheet has been detached to uncover the test strip opening, the upper flexible sheet, lance body and test strip can be bent to deploy the dermal tissue penetration member from the lance body opening. A kit includes the packaged medical device described above and a deployment device for detaching the lower flexible sheet and bending the upper flexible sheet, lance body and test strip to deploy the dermal tissue penetration member. A method for deploying a dermal tissue penetration member of a packed medical device includes providing the packaged medical device described above, detaching the lower flexible sheet to uncover the test strip opening and bending the upper flexible sheet, lance body and test strip to deploy the dermal tissue penetration member.
Abstract:
An hydraulic latch for selectively securing and, when necessary, automatically releasing capillary tubing suspended in a well bore in a manner affording clearance of a subsurface safety valve through which the suspended capillary tubing is suspended prior to release.
Abstract:
A device that includes a proteinaceous factor is disclosed. The proteinaceous factor is encoded by the nucleotide sequence of any one of SEQ ID NO.: 1, a degenerate variant of SEQ ID NO.: 1, and a complement of SEQ ID NO.: 1. The proteinaceous factor may be a recombinant. In addition, the device may include any one of (i) Immunoglobulin G (IgG) bound non-specially to the proteinaceous factor, (ii) at least one diagnostic label bound to the proteinaceous factor, (iii) Immunoglobulin G bound non-specially to the proteinaceous factor and at least one diagnostic label bound to the proteinaceous factor, and (iv) at least one base supporting the proteinaceous factor.
Abstract:
A device that includes a proteinaceous factor is disclosed. The proteinaceous factor is encoded by the nucleotide sequence of any one of SEQ ID NO.: 1, a degenerate variant of SEQ ID NO.: 1, and a complement of SEQ ID NO.: 1. The proteinaceous factor may be a recombinant. In addition, the device may include any one of (i) Immunoglobulin G (IgG) bound non-specially to the proteinaceous factor, (ii) at least one diagnostic label bound to the proteinaceous factor, (iii) Immunoglobulin G bound non-specially to the proteinaceous factor and at least one diagnostic label bound to the proteinaceous factor, and (iv) at least one base supporting the proteinaceous factor.
Abstract:
A system, method, and software for optimizing the commingling of well fluids from a plurality of producing subsea wells. The mixing temperature and water content in each header of a collection manifold are calculated for each subsea well and header combinations, responsive to data from sensors at the collection manifold. Combinations with conditions outside operational limits are then discarded. Remaining combinations are ranked based on predetermined optimization criteria. The ranked combinations are provided for the operator for optimizing flow properties and well fluid production. The calculations can restart with new, real-time sensed values from the subsea collection manifold.
Abstract:
A rotary cultivator (10) has an elongate tubular handle member (12), a cultivator tool (14) rotatably mounted at one end of the handle member (12) and an electric motor drive unit (16) mounted at the other end of the handle member (12), the handle member (12) being curved adjacent the end to which the cultivator tool (14) is mounted, a flexible drive element (22) extending within the tubular handle member (12), the flexible drive element (22) being connected directly at one end to the electric motor drive unit (16) and at the other end to the cultivator tool (14).
Abstract:
A device and method for measuring clotting times in a fluid, typically blood, within a microchannel, with the onset of clotting being determined by measurement of the rate of change, or the value, of capacitance or impedance between two electrodes situated on either side of the microchannel. The device includes an upper support member and a lower support member with a microchannel formed therein. The device also includes electrodes situated along the length of the microchannel.